Prof Dimitra Kiritsi, Aristotle University of Thessaloniki, is joining our Family Forum online to talk about the recently published results of the REFLECT study. In this phase 1/2 clinical trial, losartan was well tolerated by children with RDEB, and the trial provided preliminary evidence of a reduction in disease burden.
Join Sharmila and Kate as they chat with Dimitra to find out more about the trial and what this means for patients with RDEB. There will be plenty of time to ask questions, so do join us for our last Family Forum event of 2024.